Skip to main content

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca
Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Angel García Jiménez

Angel García Jiménez

Biomedical Research in Gynaecology
Read more
Manuel Alanis Bernal

Manuel Alanis Bernal

Research technician
Research Group on Status Epilepticus and Acute Seizures
Read more
Amarilis Sofia Baekelandt

Amarilis Sofia Baekelandt

Predoctoral researcher
Cardiovascular Diseases
Read more
Sílvia Torrents Zapata

Sílvia Torrents Zapata

Research technician
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.